Citations (109)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Alzira Alves De Siqueira Carvalho, Cyril Tychon & Laurent Servais. (2023) Newborn screening for spinal muscular atrophy - what have we learned?. Expert Review of Neurotherapeutics 23:11, pages 1005-1012.
Read now
Read now
Helgi Thor Hjartarson, Kristofer Nathorst-Böös & Thomas Sejersen. (2022) Disease Modifying Therapies for the Management of Children with Spinal Muscular Atrophy (5q SMA): An Update on the Emerging Evidence. Drug Design, Development and Therapy 16, pages 1865-1883.
Read now
Read now
Hugh J. McMillan, Crystal M. Proud, Michelle A. Farrar, Ian E. Alexander, Francesco Muntoni & Laurent Servais. (2022) Onasemnogene abeparvovec for the treatment of spinal muscular atrophy. Expert Opinion on Biological Therapy 22:9, pages 1075-1090.
Read now
Read now
Theodora Markati, Gemma Fisher, Sithara Ramdas & Laurent Servais. (2022) Risdiplam: an investigational survival motor neuron 2 (SMN2) splicing modifier for spinal muscular atrophy (SMA). Expert Opinion on Investigational Drugs 31:5, pages 451-461.
Read now
Read now
Theodora Markati, Jessica Duis & Laurent Servais. (2021) Therapies in preclinical and clinical development for Angelman syndrome. Expert Opinion on Investigational Drugs 30:7, pages 709-720.
Read now
Read now
Laurent Servais, Giovanni Baranello, Mariacristina Scoto, Aurore Daron & Maryam Oskoui. (2021) Therapeutic interventions for spinal muscular atrophy: preclinical and early clinical development opportunities. Expert Opinion on Investigational Drugs 30:5, pages 519-527.
Read now
Read now
Maria Jędrzejowska. (2020) Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular Atrophy. Degenerative Neurological and Neuromuscular Disease 10, pages 39-47.
Read now
Read now
Maria Stefanova Kamusheva & Maria Jordanova Dimitrova. (2020) Clinical and economic assessment of nusinersen: the Bulgarian perspective. Expert Opinion on Orphan Drugs 8:10, pages 403-415.
Read now
Read now
Sithara Ramdas & Laurent Servais. (2020) New treatments in spinal muscular atrophy: an overview of currently available data. Expert Opinion on Pharmacotherapy 21:3, pages 307-315.
Read now
Read now
Articles from other publishers (100)
Graeme O'Connor, Lisa Edel, Sarah Raquq, Melissa Bowerman, Agnieszka Szmurlo, Zoe Simpson, Isobel Hardy, Mary Fewtrell & Giovanni Baranello. (2022) Open‐labelled study to monitor the effect of an amino acid formula on symptom management in children with spinal muscular atrophy type I: The SMAAF pilot study. Nutrition in Clinical Practice 38:4, pages 871-880.
Crossref
Crossref
Almala Pinar Ergenekon, Zeynep Gümüş, Cansu Yilmaz Yegit, Muruvvet Cenk, Aynur Gulieva, Mine Kalyoncu, Merve Selcuk, Seyda Karabulut, Gulten Ozturk, Ela Erdem Eralp, Olcay Unver, Bulent Karadag & Yasemin Gokdemir. (2023) Depression, anxiety, and sleep quality of caregivers of children with spinal muscular atrophy. Pediatric Pulmonology 58:6, pages 1697-1702.
Crossref
Crossref
Rafael S. Rodriguez-Torres, David Uher, Emma L. Gay, Giorgia Coratti, Sally Dunaway Young, Annemarie Rohwer, Robert Muni Lofra, Darryl C. De Vivo, Michio Hirano, Nancy W. Glynn & Jacqueline Montes. (2023) Measuring Fatigue and Fatigability in Spinal Muscular Atrophy (SMA): Challenges and Opportunities. Journal of Clinical Medicine 12:10, pages 3458.
Crossref
Crossref
Zhaoyue Zheng, Jingya Ye, Mi Leng, Chunmei Gan, Na Tang, Wei Li, C. Alexander Valencia, Biao Dong & Hoi Yee Chow. (2023) Enhanced sensitivity of neutralizing antibody detection for different AAV serotypes using HeLa cells with overexpressed AAVR. Frontiers in Pharmacology 14.
Crossref
Crossref
Mandana Arbab, Zaneta Matuszek, Kaitlyn M. Kray, Ailing Du, Gregory A. Newby, Anton J. Blatnik, Aditya Raguram, Michelle F. Richter, Kevin T. Zhao, Jonathan M. Levy, Max W. ShenW. David Arnold, Dan Wang, Jun Xie, Guangping Gao, Arthur H. M. Burghes & David R. Liu. (2023) Base editing rescue of spinal muscular atrophy in cells and in mice. Science 380:6642.
Crossref
Crossref
Dian Marta Sari, Vitriana Biben, Guswan Wiwaha & Dany Hilmanto. (2023) Association between spinal muscular atrophy type and delayed diagnosis and the risk of spinal deformity in Indonesian patients. European Journal of Medical Research 28:1.
Crossref
Crossref
. (2023) Seelische Notlage und später Schwangerschaftsabbruch. Ethik in der Medizin.
Crossref
Crossref
Didu S Kariyawasam, Arlene M D'Silva, Hugo Sampaio, Nancy Briggs, Karen Herbert, Veronica Wiley & Michelle A Farrar. (2023) Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study. The Lancet Child & Adolescent Health 7:3, pages 159-170.
Crossref
Crossref
Anton Novikov, Maria Maldova, Natalia Shandybina, Ivan Shalmiev, Elena Shoshina, Natalia Epoyan & Tatiana Moshonkina. (2023) First Use of Non-Invasive Spinal Cord Stimulation in Motor Rehabilitation of Children with Spinal Muscular Atrophy. Life 13:2, pages 449.
Crossref
Crossref
Saad Alkahtani, Norah S. AL-Johani & Saud Alarifi. (2023) Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects. International Journal of Molecular Sciences 24:2, pages 1340.
Crossref
Crossref
Magali Ngawa, Fabian Dal Farra, Andrei-Dan Marinescu & Laurent Servais. (2023) Longitudinal developmental profile of newborns and toddlers treated for spinal muscular atrophy. Therapeutic Advances in Neurological Disorders 16, pages 175628642311543.
Crossref
Crossref
Owen Martyn Bendor-Samuel, Tabitha Wishlade, Louise Willis, Parvinder Aley, Edward Choi, Rachel Craik, Yama Mujadidi, Ginny Mounce, Fenella Roseman, Arancha De La Horra Gozalo, James Bland, Nazia Taj, Ian Smith, Anette-Gabriele Ziegler, Ezio Bonifacio, Christiane Winkler, Florian Haupt, John A Todd, Laurent Servais, Matthew D Snape & Manu Vatish. (2023) Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials. Archives of Disease in Childhood 108:1, pages 26-30.
Crossref
Crossref
Tamara Dangouloff, Mickael Hiligsmann, Nicolas Deconinck, Adèle D'Amico, Andreea M. Seferian, François Boemer & Laurent Servais. (2022) Financial cost and quality of life of patients with spinal muscular atrophy identified by symptoms or newborn screening. Developmental Medicine & Child Neurology 65:1, pages 67-77.
Crossref
Crossref
Lucy Lee, Rakesh Gollen, Anas M. Fathallah, Lan Gao & Shivakumar Patil. (2022) Bridging the Gap With Clinical Pharmacology in Innovative Rare Disease Treatment Modalities: Targeting DNA to RNA to Protein. The Journal of Clinical Pharmacology 62:S2.
Crossref
Crossref
Lisa Belter, Allison Mazzella, Shannon O’Brien & Jill Jarecki. (2022) Knowledge of genetic test results among caregivers and individuals with spinal muscular atrophy. PLOS ONE 17:11, pages e0276756.
Crossref
Crossref
John W. Day, Kelly Howell, Amy Place, Kimberly Long, Jose Rossello, Nathalie Kertesz & George Nomikos. (2022) Advances and limitations for the treatment of spinal muscular atrophy. BMC Pediatrics 22:1.
Crossref
Crossref
Michael P. Moazami & Matthew J.A. Wood. (2022) RNase-H-mediated silencing in the CNS proves predictably nontrivial. Med 3:11, pages 733-734.
Crossref
Crossref
Kristin J Krosschell, Sally Dunaway Young, Ilse Peterson, Mary Curry, Allison Mazzella, Jill Jarecki & Rosángel Cruz. (2022) Clinical and Research Readiness for Spinal Muscular Atrophy: The Time Is Now for Knowledge Translation. Physical Therapy 102:10.
Crossref
Crossref
Marisa E. Schwab, Shirley Shao, Li Zhang, Billie Lianoglou, Lisa Belter, Jill Jarecki, Mary Schroth, Charlotte J. Sumner & Tippi MacKenzie. (2022) Investigating attitudes toward prenatal diagnosis and fetal therapy for spinal muscular atrophy. Prenatal Diagnosis 42:11, pages 1409-1419.
Crossref
Crossref
Benjamin Stolte, Olivia Schreiber-Katz, René Günther, Claudia Diana Wurster, Susanne Petri, Alma Osmanovic, Maren Freigang, Zeljko UzelacMarkus Leo, Otgonzul von VelsenWibke Bayer, Ulf DittmerChristoph Kleinschnitz & Tim Hagenacker. (2022) Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy. Human Gene Therapy 33:17-18, pages 968-976.
Crossref
Crossref
Theodora Markati, Maryam Oskoui, Michelle A Farrar, Tina Duong, Nathalie Goemans & Laurent Servais. (2022) Emerging therapies for Duchenne muscular dystrophy. The Lancet Neurology 21:9, pages 814-829.
Crossref
Crossref
Shreyashee Mallik, Charles G. Bailey & John E. J. Rasko. (2022) Approved gene therapies in Australia: coming to a store near you. Internal Medicine Journal 52:8, pages 1313-1321.
Crossref
Crossref
Eugenio Mercuri, Giovanni Baranello, Odile Boespflug‐Tanguy, Liesbeth De Waele, Nathalie Goemans, Janbernd Kirschner, Riccardo Masson, Elena S. Mazzone, Astrid Pechmann, Maria Carmela Pera, Carole Vuillerot, Silvia Bader‐Weder, Marianne Gerber, Ksenija Gorni, Janine Hoffart, Heidemarie Kletzl, Carmen Martin, Tammy McIver, Renata S. Scalco, Wai Yin Yeung & Laurent Servais. (2022) Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment. European Journal of Neurology.
Crossref
Crossref
Stuart J. Grice & Ji-Long Liu. (2022) Motor defects in a Drosophila model for spinal muscular atrophy result from SMN depletion during early neurogenesis. PLOS Genetics 18:7, pages e1010325.
Crossref
Crossref
Federica S. Ricci, Rossella D’Alessandro, Martina Vacchetti, Anna Salvalaggio, Alessandra Somà, Giorgia Daffunchio, Marco Spada, Renato Turra, Marisa Bobbio, Alessandro Ciuti, Chiara Davico, Benedetto Vitiello & Tiziana E. Mongini. (2022) Improving Recognition of Treatable Rare Neuromuscular Disorders in Primary Care: A Pilot Feasibility Study. Children 9:7, pages 1063.
Crossref
Crossref
Harriet Weststrate, Georgia Stimpson, Lily Thomas, Mariacristina Scoto, Emily Johnson, Alexandra Stewart, Francesco Muntoni, Giovanni Baranello, Eleanor Conway, Adnan Manzur, Pinki Munot, Marion Main & Claudia Kate Au‐Yeung. (2022) Evolution of bulbar function in spinal muscular atrophy type 1 treated with nusinersen. Developmental Medicine & Child Neurology 64:7, pages 907-914.
Crossref
Crossref
Arnaud Monseur, Bradley P. Carlin, Bruno Boulanger, Andreea Seferian, Laurent Servais, Chris Freitag, Leen Thielemans, Teresa Gidaro, Elena Gargaun, Virginie Chê, Ulrike Schara, Andrea Gangfuß, Adele D’Amico, James J. Dowling, Basil T. Darras, Aurore Daron, Arturo Hernandez, Capucine de Lattre, Jean-Michel Arnal, Michèle Mayer, Jean-Marie Cuisset, Carole Vuillerot, Stéphanie Fontaine, Rémi Bellance, Valérie Biancalana, Ana Buj-Bello, Jean-Yves Hogrel, Hal Landy, Kimberly Amburgey, Barbara Andres, Enrico Bertini, Ruxandra Cardas, Séverine Denis, Dominique Duchêne, Virginie Latournerie, Nacera Reguiba, Etsuko Tsuchiya & Carina Wallgren-Pettersson. (2021) Leveraging Natural History Data in One- and Two-Arm Hierarchical Bayesian Studies of Rare Disease Progression. Statistics in Biosciences 14:2, pages 237-258.
Crossref
Crossref
Irina T. Zaharieva, Mariacristina Scoto, Karolina Aragon‐Gawinska, Deborah Ridout, Bruno Doreste, Laurent Servais, Francesco Muntoni & Haiyan Zhou. (2022)
Response of plasma
microRNAs
to nusinersen treatment in patients with
SMA
. Annals of Clinical and Translational Neurology 9:7, pages 1011-1026.
Crossref
Crossref
Kimberly Goodspeed, Rachel M. Bailey, Suyash Prasad, Chanchal Sadhu, Jessica A. Cardenas, Mary Holmay, Deborah A. Bilder & Berge A. Minassian. (2022) Gene Therapy: Novel Approaches to Targeting Monogenic Epilepsies. Frontiers in Neurology 13.
Crossref
Crossref
Richard S. Finkel, Monique M. Ryan, Samuel Ignacio Pascual Pascual, John W. Day, Eugenio Mercuri, Darryl C. De Vivo, Richard Foster, Jacqueline Montes, Juliana Gurgel‐Giannetti, Drew MacCannell & Zdenek Berger. (2022) Scientific rationale for a higher dose of nusinersen. Annals of Clinical and Translational Neurology 9:6, pages 819-829.
Crossref
Crossref
Benedikt Becker, Isabell Cordts & Marcus Deschauer. (2022) Intrafamiliäre Variabilität des Phänotyps der 5q-assoziierten spinalen Muskelatrophie am Beispiel von 2 Geschwistern. Nervenheilkunde 41:05, pages 346-349.
Crossref
Crossref
Bárbara B. Mendes, João Conniot, Aviram Avital, Dongbao Yao, Xingya Jiang, Xiang Zhou, Noga Sharf-Pauker, Yuling Xiao, Omer Adir, Haojun Liang, Jinjun Shi, Avi Schroeder & João Conde. (2022) Nanodelivery of nucleic acids. Nature Reviews Methods Primers 2:1.
Crossref
Crossref
I. Pitarch Castellano, M. Cabrera-Serrano, R. Calvo Medina, M.G. Cattinari, S. Espinosa García, J.A. Fernández-Ramos, O. García Campos, D. Gómez-Andrés, M.A. Grimalt Calatayud, A.J. Gutiérrez Martínez, E. Ibáñez Albert, S. Kapetanovic García, M. Madruga-Garrido, M. Martínez-Moreno, J. Medina Cantillo, A.I. Melián Suárez, A. Moreno Escribano, F. Munell, A. Nascimento Osorio, S.I. Pascual-Pascual, M. Povedano, I.M. Santana Casiano & J.F. Vázquez-Costa. (2022) Delphi consensus on recommendations for the treatment of spinal muscular atrophy in Spain (RET-AME consensus). Neurología (English Edition) 37:3, pages 216-228.
Crossref
Crossref
I. Pitarch Castellano, M. Cabrera-Serrano, R. Calvo Medina, M.G. Cattinari, S. Espinosa García, J.A. Fernández-Ramos, O. García Campos, D. Gómez-Andrés, M.A. Grimalt Calatayud, A.J. Gutiérrez Martínez, E. Ibáñez Albert, S. Kapetanovic García, M. Madruga-Garrido, M. Martínez-Moreno, J. Medina Cantillo, A.I. Melián Suárez, A. Moreno Escribano, F. Munell, A. Nascimento Osorio, S.I. Pascual-Pascual, M. Povedano, I.M. Santana Casiano & J.F. Vázquez-Costa. (2022) Consenso Delphi de las recomendaciones para el tratamiento de los pacientes con atrofia muscular espinal en España (consenso RET-AME). Neurología 37:3, pages 216-228.
Crossref
Crossref
Noman Paracha, Pollyanna Hudson, Stephen Mitchell & C. Simone Sutherland. (2021) Systematic Literature Review to Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management. PharmacoEconomics 40:S1, pages 11-38.
Crossref
Crossref
Michael Benatar, Joanne Wuu, Caroline McHutchison, Ronald B Postuma, Bradley F Boeve, Ronald Petersen, Christopher A Ross, Howard Rosen, Jalayne J Arias, Stephanie Fradette, Michael P McDermott, Jeremy Shefner, Christine Stanislaw, Sharon Abrahams, Stephanie Cosentino, Peter M Andersen, Richard S Finkel, Volkan Granit, Anne-Laure Grignon, Jonathan D Rohrer, Corey T McMillan, Murray Grossman, Ammar Al-Chalabi, Martin R Turner, Ammar Al-Chalabi, Peter M Andersen, Jalayne Arias, Michael Benatar, Bradley Boeve, Stephanie Cosentino, Kuldip Dave, Toby Ferguson, Mary-Kay Floeter, Jonathan Rohrer, Stephanie Fradette, Tania Gendron, Volkan Granit, Anne-Laure Grignon, Murray Grossman, Amelie Gubitz, Petra Kaufman, Isabelle Le Ber, Suzee Lee, Andrea Malaspina, Michael P McDermott, Caroline McHutchison, Corey McMillan, Katie Nicholson, Ronald Petersen, Ronald Postuma, Richard Robinson, Howard Rosen, Christopher Ross, Jeremy Shefner, Christine Stanislaw, Nadine Tatton, Neil Thakur, Martin Turner, Jochen Weishaupt & Joanne Wuu. (2022) Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases. Brain 145:1, pages 27-44.
Crossref
Crossref
Jana Haberlová, Petra Hedvičáková, Petra Fuchsová, Markéta Jílková, Lucie Holubová & Tereza Doušová. (2022) Spinal muscular atrophy in childhood - actual treatment options . Neurologie pro praxi 23:1, pages 9-13.
Crossref
Crossref
Margherita Bersani, Mafalda Rizzuti, Elisa Pagliari, Manuela Garbellini, Domenica Saccomanno, Hong M. Moulton, Nereo Bresolin, Giacomo P. Comi, Stefania Corti & Monica Nizzardo. (2022) Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model. Molecular Therapy 30:3, pages 1288-1299.
Crossref
Crossref
Muhammad I. Munshi, Sarah J. Yao & Choukri Ben Mamoun. (2022) Redesigning therapies for pantothenate kinase–associated neurodegeneration. Journal of Biological Chemistry 298:3, pages 101577.
Crossref
Crossref
Crystal J. J. Yeo, Zachary Simmons, Darryl C. De Vivo & Basil T. Darras. (2022) Ethical Perspectives on Treatment Options with Spinal Muscular Atrophy Patients. Annals of Neurology 91:3, pages 305-316.
Crossref
Crossref
Jeromie BallreichIjeamaka EzebiloBanda Abdallah KhalifaJoshua ChoeGerard Anderson. (2022) Coverage of genetic therapies for spinal muscular atrophy across fee-for-service Medicaid programs. Journal of Managed Care & Specialty Pharmacy 28:1, pages 39-47.
Crossref
Crossref
Almala Pinar Ergenekon, Cansu Yilmaz Yegit, Muruvvet Cenk, Yasemin Gokdemir, Ela Erdem Eralp, Gulten Ozturk, Olcay Unver, Ozge Kenis Coskun, Evrim Karadag Saygi, Dilsad Turkdogan & Bulent Karadag. (2022) Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen. Pediatrics International 64:1.
Crossref
Crossref
Laurent Servais & Philip Van Damme. 2022. Emergencies in Neuromuscular Disorders. Emergencies in Neuromuscular Disorders
155
180
.
Larissa Goli, Jessica Stoodley, Suzan M. Hammond & Richard Raz. 2022. Cell Penetrating Peptides. Cell Penetrating Peptides
491
513
.
Sergei A. Kurbatov. (2021) Spinal Muscular Atrophy 5q under the Mask of Myopathy: 10 Clinical Cases. Current Pediatrics 20:6s, pages 576-580.
Crossref
Crossref
Siiri Sarv, Tiina Kahre, Eve Vaidla, Sander Pajusalu, Kai Muru, Haide Põder, Katrin Gross-Paju, Sandra Ütt, Riina Žordania, Inga Talvik, Eve Õiglane-Shlik, Kristina Muhu & Katrin Õunap. (2021) The Birth Prevalence of Spinal Muscular Atrophy: A Population Specific Approach in Estonia. Frontiers in Genetics 12.
Crossref
Crossref
Xin Zhao, Zhihua Feng, Nicole Risher, Anna Mollin, Josephine Sheedy, Karen K Y Ling, Jana Narasimhan, Amal Dakka, John D Baird, Hasane Ratni, Catherine Lutz, Karen S Chen, Nikolai A Naryshkin, Chien-Ping Ko, Ellen Welch, Friedrich Metzger & Marla Weetall. (2022) SMN protein is required throughout life to prevent spinal muscular atrophy disease progression. Human Molecular Genetics 31:1, pages 82-96.
Crossref
Crossref
Tamara Dangouloff, Camille Botty, Charlotte Beaudart, Laurent Servais & Mickaël Hiligsmann. (2021) Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Eve Fouarge, Arnaud Monseur, Bruno Boulanger, Mélanie Annoussamy, Andreea M. Seferian, Silvana De Lucia, Charlotte Lilien, Leen Thielemans, Khazal Paradis, Belinda S. Cowling, Chris Freitag, Bradley P. Carlin & Laurent Servais. (2021) Hierarchical Bayesian modelling of disease progression to inform clinical trial design in centronuclear myopathy. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Lucas Mix, Olivia Schreiber-Katz, Claudia D. Wurster, Zeljko Uzelac, Sophia Platen, Christina Gipperich, Gresa Ranxha, Gary Wieselmann, Alma Osmanovic, Albert C. Ludolph, Susanne Petri & Dorothée Lulé. (2021) Executive function is inversely correlated with physical function: the cognitive profile of adult Spinal Muscular Atrophy (SMA). Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Mary Curry, Rosángel Cruz, Lisa Belter, Mary Schroth, Megan Lenz & Jill Jarecki. (2021) Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA). BMC Pediatrics 21:1.
Crossref
Crossref
Yumi Cleary, Michael Gertz, Paul Grimsey, Andreas Günther, Katja Heinig, Kayode Ogungbenro, Leon Aarons, Aleksandra Galetin & Heidemarie Kletzl. (2021) Model‐Based Drug–Drug Interaction Extrapolation Strategy From Adults to Children: Risdiplam in Pediatric Patients With Spinal Muscular Atrophy. Clinical Pharmacology & Therapeutics 110:6, pages 1547-1557.
Crossref
Crossref
Giovanni Baranello, Ksenija Gorni, Monica Daigl, Anna Kotzeva, Rachel Evans, Neil Hawkins, David A. Scott, Anadi Mahajan, Francesco Muntoni & Laurent Servais. (2021) Prognostic Factors and Treatment‐Effect Modifiers in Spinal Muscular Atrophy. Clinical Pharmacology & Therapeutics 110:6, pages 1435-1454.
Crossref
Crossref
Nertiyan Elangkovan & George Dickson. (2021) Gene Therapy for Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases 8:s2, pages S303-S316.
Crossref
Crossref
Matthew J. Lennon, Grant Rigney, Vanessa Raymont & Perminder Sachdev. (2021) Genetic Therapies for Alzheimer’s Disease: A Scoping Review. Journal of Alzheimer's Disease 84:2, pages 491-504.
Crossref
Crossref
Hui Wen Loh, Wanrong Hong, Chui Ping Ooi, Subrata Chakraborty, Prabal Datta Barua, Ravinesh C. Deo, Jeffrey Soar, Elizabeth E. Palmer & U. Rajendra Acharya. (2021) Application of Deep Learning Models for Automated Identification of Parkinson’s Disease: A Review (2011–2021). Sensors 21:21, pages 7034.
Crossref
Crossref
Katarzyna Kotulska, Aviva Fattal-Valevski & Jana Haberlova. (2021) Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular Atrophy. Frontiers in Neurology 12.
Crossref
Crossref
François Boemer, Jean-Hubert Caberg, Pablo Beckers, Vinciane Dideberg, Samantha di Fiore, Vincent Bours, Sandrine Marie, Joseph Dewulf, Lionel Marcelis, Nicolas Deconinck, Aurore Daron, Laura Blasco-Perez, Eduardo Tizzano, Mickaël Hiligsmann, Jacques Lombet, Tatiana Pereira, Lucia Lopez-Granados, Sarvnaz Shalchian-Tehran, Véronique van Assche, Arabelle Willems, Sofie Huybrechts, Bénédicte Mast, Rudolf van Olden, Tamara Dangouloff & Laurent Servais. (2021) Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium. Scientific Reports 11:1.
Crossref
Crossref
Tamara Dangouloff, François Boemer & Laurent Servais. (2021) Newborn screening of neuromuscular diseases. Neuromuscular Disorders 31:10, pages 1070-1080.
Crossref
Crossref
Charlotte Lilien, Harmen Reyngoudt, Andreea Mihaela Seferian, Teresa Gidaro, Mélanie Annoussamy, Virginie Chê, Valérie Decostre, Isabelle Ledoux, Julien Le Louër, Eric Guemas, Francesco Muntoni, Jean‐Yves Hogrel, Pierre Georges Carlier & Laurent Servais. (2021) Upper limb disease evolution in exon 53 skipping eligible patients with Duchenne muscular dystrophy. Annals of Clinical and Translational Neurology 8:10, pages 1938-1950.
Crossref
Crossref
Daniele Guadagnolo, Maria Piane, Maria Rosaria Torrisi, Antonio Pizzuti & Simona Petrucci. (2021) Genotype-Phenotype Correlations in Monogenic Parkinson Disease: A Review on Clinical and Molecular Findings. Frontiers in Neurology 12.
Crossref
Crossref
Vanessa Luiza Romanelli Tavares, Frederico Monfardini, Naila Cristina Vilaça Lourenço, Katia Maria da Rocha, Karina Weinmann, Rita Pavanello & Mayana Zatz. (2021) Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs. International Journal of Neonatal Screening 7:3, pages 53.
Crossref
Crossref
Nathaniel G. Girer, Victoria G. Rontoyanni, Aditya Joshi, Igor Patrikeev, Andrew J. Murton, Craig Porter, Massoud Motamedi & Cornelis J. Elferink. (2021) Liver-Specific Nonviral Gene Delivery of Fibroblast Growth Factor 21 Protein Expression in Mice Regulates Body Mass and White/Brown Fat Respiration. Journal of Pharmacology and Experimental Therapeutics 378:2, pages 157-165.
Crossref
Crossref
Juyeon Kakazu, Nakoma L. Walker, Katherine Claire Babin, Katherine A. Trettin, Christopher Lee, Patricia B. Sutker, Adam M. Kaye & Alan D. Kaye. (2021) Risdiplam for the Use of Spinal Muscular Atrophy. Orthopedic Reviews 13:2.
Crossref
Crossref
Helena Chaytow, Kiterie M.E. Faller, Yu-Ting Huang & Thomas H. Gillingwater. (2021) Spinal muscular atrophy: From approved therapies to future therapeutic targets for personalized medicine. Cell Reports Medicine 2:7, pages 100346.
Crossref
Crossref
Abduljabber Alhammoud, Yahya Othman, Ron El-Hawary, William G. Mackenzie & Jason J. Howard. (2021) The impact of scoliosis surgery on pulmonary function in spinal muscular atrophy: a systematic review. Spine Deformity 9:4, pages 913-921.
Crossref
Crossref
Kshea Hale, Jelili Ojodu & Sikha Singh. (2021) Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021. International Journal of Neonatal Screening 7:3, pages 33.
Crossref
Crossref
Tamara Dangouloff, Eva Vrščaj, Laurent Servais, Damjan Osredkar, Thierry Adoukonou, Omid Aryani, Nina Barisic, Fahad Bashiri, Laila Bastaki, Afaf Benitto, Tawfeg Ben Omran, Guenther Bernert, Enrico Bertini, Patricia Borde, Peter Born, Rose-Mary Boustani, Nina Butoianu, Claudia Castiglioni, Feriha Catibusic, Sophelia Chan, Yin Hsiu Chien, Kyproula Christodoulou, Donniphat Dejsuphong, Michelle Farrar, Duma Filip, Nathalie Goemans, Kokou Guinhouya, Jana Haberlova, Kinga Hadzsiev, Kristine Hovhannesyan, Pirjo Isohanni, Nelica Ivanovic Radovic, David Jacquier, Alusine Jalloh, Maria Jedrzejowska, Gwen Kandawasvika, Celestin Kaputu, Nfwama Kawatu, Kristin Kernohan, Jan Kirschner, Barbara Klink, Sherry Kodsy, Ange-Eric Kouame-Assouan, Ruzica Kravljanac, Madara Kreile, Ivan Litvinenko, Hugh McMillan, Sandra Mesa, Inaam Mohamed, Liljana Muaremoska Kanzoska, Yoram Nevo, Seraphin Nguefack, Kafula Nkole, Gina O'Grady, Declan O'Rourke, Maryam Oskoui, Flavia Piazzon, Dimitri Poddighe, Audrone Prasauskiene, Juan Prieto, Magnhild Rasmussen, Santara Razafindrasata, Narayan Saha, Kayoko Saito, Foksouna Sakadi, Modibo Sangare, Mary Schroth, Leanid Shalkevich, Andriy Shatillo, Renu Suthar, Lena Szabo, Nana Tatishvili, Meriem Tazir, Eduardo Tizzano, Haluk Topaloglu, Mar Tulinius, Ludo van der Pol, Gabriel Vazquez, Dimitry Vlodavets, Jithangi Wanigasinghe, Jo Wilmshurst, Hui Xiong, Dimitrios Zafeiriou & Eleni Zamba. (2021) Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go. Neuromuscular Disorders 31:6, pages 574-582.
Crossref
Crossref
Danielle Paige Anthony, Manasa Hegde, Shreya S. Shetty, Thasneema Rafic, Srinivas Mutalik & B.S. Satish Rao. (2021) Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases. Life Sciences 274, pages 119326.
Crossref
Crossref
Fahad A. Bashiri, Mohamad-Hani Temsah, Khalid Hundallah, Fahad Alsohime & Yazed AlRuthia. (2021) 2020 Update to Spinal Muscular Atrophy Management in Saudi Arabia. Frontiers in Pediatrics 9.
Crossref
Crossref
B. Monica Bowen, Rebecca Truty, Swaroop Aradhya, Sara L. Bristow, Britt A. Johnson, Ana Morales, Christopher A. Tan, M. Jody Westbrook, Thomas L. Winder & Juan C. Chavez. (2021) SMA Identified: Clinical and Molecular Findings From a Sponsored Testing Program for Spinal Muscular Atrophy in More Than 2,000 Individuals. Frontiers in Neurology 12.
Crossref
Crossref
Susan E. Matesanz, Vanessa Battista, Jean Flickinger, Jennifer N. Jones & Elizabeth A. Kichula. (2021) Clinical Experience With Gene Therapy in Older Patients With Spinal Muscular Atrophy. Pediatric Neurology 118, pages 1-5.
Crossref
Crossref
Miriam Kolníková, Karin Viestová, Patrícia Balážová, Katarína Okáľová, Eva Trúsiková, Eva Lazarová & Jaroslav Čižmár. (2021) Spinal muscular atrophy - first experiences with nusinersen therapy in Slovakia. Neurologie pro praxi 22:2, pages 114-120.
Crossref
Crossref
Stefan Nicolau, Megan A. Waldrop, Anne M. Connolly & Jerry R. Mendell. (2021) Spinal Muscular Atrophy. Seminars in Pediatric Neurology 37, pages 100878.
Crossref
Crossref
Katerina Kucera, Jennifer Taylor, Veronica Robles, Kristin Clinard, Brooke Migliore, Beth Boyea, Katherine Okoniewski, Martin Duparc, Catherine Rehder, Scott Shone, Zheng Fan, Melissa Raspa, Holly Peay, Anne Wheeler, Cynthia Powell, Donald Bailey & Lisa Gehtland. (2021) A Voluntary Statewide Newborn Screening Pilot for Spinal Muscular Atrophy: Results from Early Check. International Journal of Neonatal Screening 7:1, pages 20.
Crossref
Crossref
Alma Osmanovic, Olivia Schreiber-Katz & Susanne Petri. (2021) Nusinersen Wearing-Off in Adult 5q-Spinal Muscular Atrophy Patients. Brain Sciences 11:3, pages 367.
Crossref
Crossref
Gabriel Ocana-Santero, Javier Díaz-Nido & Saúl Herranz-Martín. (2021) Future Prospects of Gene Therapy for Friedreich’s Ataxia. International Journal of Molecular Sciences 22:4, pages 1815.
Crossref
Crossref
Mélanie Annoussamy, Andreea M. Seferian, Aurore Daron, Yann Péréon, Claude Cances, Carole Vuillerot, Liesbeth De Waele, Vincent Laugel, Ulrike Schara, Teresa Gidaro, Charlotte Lilien, Jean‐Yves Hogrel, Pierre Carlier, Emmanuel Fournier, Linda Lowes, Ksenija Gorni, Myriam Ly‐Le Moal, Nicole Hellbach, Timothy Seabrook, Christian Czech, Ricardo Hermosilla & Laurent Servais. (2020) Natural history of Type 2 and 3 spinal muscular atrophy: 2‐year NatHis‐SMA study. Annals of Clinical and Translational Neurology 8:2, pages 359-373.
Crossref
Crossref
Bhavya RaviMichelle Harran Chan-Cortés & Charlotte J. Sumner. (2021) Gene-Targeting Therapeutics for Neurological Disease: Lessons Learned from Spinal Muscular Atrophy. Annual Review of Medicine 72:1, pages 1-14.
Crossref
Crossref
Anne Rietz, Kevin J Hodgetts, Hrvoje Lusic, Kevin M Quist, Erkan Y Osman, Christian L Lorson & Elliot J Androphy. (2020) Short-duration splice promoting compound enables a tunable mouse model of spinal muscular atrophy. Life Science Alliance 4:1, pages e202000889.
Crossref
Crossref
Xiaoying Zhu. (2021) Comparison of Nusinersen and Evrysdi in the Treatment of Spinal Muscular Atrophy. E3S Web of Conferences 271, pages 03035.
Crossref
Crossref
Ivon Cuscó, Sara Bernal, Laura Blasco-Pérez, Maite Calucho, Laura Alias, Pablo Fuentes-Prior & Eduardo F. Tizzano. (2020)
Practical guidelines to manage discordant situations of
SMN2
copy number in patients with spinal muscular atrophy
. Neurology Genetics 6:6, pages e530.
Crossref
Crossref
Yuri Yépez, Irene Paradisi & Sergio Arias. (2020) Spinal muscular atrophy in Venezuela: quantitative analysis of SMN1 and SMN2 genes. Egyptian Journal of Medical Human Genetics 21:1.
Crossref
Crossref
Anne Troike Stratton, Richard Ogden Roberts III, Oren Kupfer, Terri Carry, Julie Parsons & Susan Apkon. (2020) Pediatric neuromuscular disorders: Care considerations during the COVID-19 pandemic. Journal of Pediatric Rehabilitation Medicine 13:3, pages 405-414.
Crossref
Crossref
Jonathan J. Darrow, Monica Sharma, Mansa Shroff & Anita K. Wagner. (2020) Efficacy and costs of spinal muscular atrophy drugs. Science Translational Medicine 12:569.
Crossref
Crossref
Ai-Ming Yu, Young Hee Choi & Mei-Juan Tu. (2020) RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges. Pharmacological Reviews 72:4, pages 862-898.
Crossref
Crossref
Jessica L. Centa, Francine M. Jodelka, Anthony J. Hinrich, Tyler B. Johnson, Joseph Ochaba, Michaela Jackson, Dominik M. Duelli, Jill M. Weimer, Frank Rigo & Michelle L. Hastings. (2020) Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease. Nature Medicine 26:9, pages 1444-1451.
Crossref
Crossref
Anastasia Gromova & Albert R. La Spada. (2020) Harmony Lost: Cell–Cell Communication at the Neuromuscular Junction in Motor Neuron Disease. Trends in Neurosciences 43:9, pages 709-724.
Crossref
Crossref
Janbernd Kirschner, Nina Butoianu, Nathalie Goemans, Jana Haberlova, Anna Kostera-Pruszczyk, Eugenio Mercuri, W. Ludo van der Pol, Susana Quijano-Roy, Thomas Sejersen, Eduardo F. Tizzano, Andreas Ziegler, Laurent Servais & Francesco Muntoni. (2020) European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy. European Journal of Paediatric Neurology 28, pages 38-43.
Crossref
Crossref
Kayla M. D. Cornett, Manoj P. Menezes, Paula Bray, Rosemary R. Shy, Isabella Moroni, Emanuela Pagliano, Davide Pareyson, Tim Estilow, Sabrina W. Yum, Trupti Bhandari, Francesco Muntoni, Matilde Laura, Mary M. Reilly, Richard S. Finkel, Katy J. Eichinger, David N. Herrmann, Michael E. Shy & Joshua Burns. (2020) Refining clinical trial inclusion criteria to optimize the standardized response mean of the CMTPedS. Annals of Clinical and Translational Neurology 7:9, pages 1713-1715.
Crossref
Crossref
Sonia Messina & Maria Sframeli. (2020) New Treatments in Spinal Muscular Atrophy: Positive Results and New Challenges. Journal of Clinical Medicine 9:7, pages 2222.
Crossref
Crossref
Jeffrey W. Santoso & Megan L. McCain. (2020) Neuromuscular disease modeling on a chip. Disease Models & Mechanisms 13:7.
Crossref
Crossref
Aravindhan Veerapandiyan, Anne M. Connolly, Richard S. Finkel, Kapil Arya, Katherine D. Mathews, Edward C. Smith, Diana Castro, Russell J. Butterfield, Julie A. Parsons, Laurent Servais, Nancy Kuntz, Vamshi K. Rao, John F. Brandsema, Eugenio Mercuri & Emma Ciafaloni. (2020) Spinal muscular atrophy care in the COVID‐19 pandemic era. Muscle & Nerve 62:1, pages 46-49.
Crossref
Crossref
M. Toffoli, S.R.L. Vieira & A.H.V. Schapira. (2020) Genetic causes of PD: A pathway to disease modification. Neuropharmacology 170, pages 108022.
Crossref
Crossref
Serena Stanga, Anna Caretto, Marina Boido & Alessandro Vercelli. (2020) Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases. International Journal of Molecular Sciences 21:10, pages 3719.
Crossref
Crossref
Siran Zhu, Saul Rooney & Gracjan Michlewski. (2020) RNA-Targeted Therapies and High-Throughput Screening Methods. International Journal of Molecular Sciences 21:8, pages 2996.
Crossref
Crossref
Wolfgang Müller-Felber, Katharina Vill, Oliver Schwartz, Dieter Gläser, Uta Nennstiel, Brunhilde Wirth, Siegfried Burggraf, Wulf Röschinger, Marc Becker, Jürgen Durner, Katja Eggermann, Christine Müller, Iris Hannibal, Bernd Olgemöller, Ulrike Schara, Astrid Blaschek & Heike Kölbel. (2020) Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening – Opportunity or Burden?1. Journal of Neuromuscular Diseases 7:2, pages 109-117.
Crossref
Crossref
Karolina Aragon‐Gawinska, Aurore Daron, Ana Ulinici, Laura Vanden Brande, Andreea Seferian, Teresa Gidaro, Mariacristina Scoto, Nicolas Deconinck, Laurent Servais, Audrey Benezit, Marie‐Laure Mathieu, Claude Cances, Julien Durigneux, Juliette Ropars, Mondher Chouchane, Peggy Forey, Leila Lazaro, Imelda Hughes, Marjorie Illingworth, Chiara Marini‐Bettolo, Inge Cuppen, Sandra Modrzejewska, Zdenka Balintova, Jana Haberlova, Kate Drimtzia, Astrid Blaschek, Gautam Ambegankoar & Melanie Annoussamy. (2019) Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen. Developmental Medicine & Child Neurology 62:3, pages 310-314.
Crossref
Crossref
Serge Braun. (2020) Thérapies géniques de l’amyotrophie spinale infantile. médecine/sciences 36:2, pages 141-146.
Crossref
Crossref
Tamara Dangouloff, Arthur Burghes, Eduardo F. Tizzano, Laurent Servais, Tamara Dangouloff, Arthur Burghes, Enrico Bertini, François Boemer, Mickaël Hiligsmann, Wolfgang Mueller-Felber, Danilo Tiziano, Philip Young, Eduardo F. Tizzano, Laurent Servais, Olga Germanenko, Mencia de Lemus, Laetitia Ouillade, Kasper Rucinski, Kristin Stephenson, Wildon Farwell, Ksenija Gorni, F. Hoffmann, Mikael Hjort & Imran Kausar. (2020) 244th ENMC international workshop: Newborn screening in spinal muscular atrophy May 10–12, 2019, Hoofdorp, The Netherlands. Neuromuscular Disorders 30:1, pages 93-103.
Crossref
Crossref